Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GENDIA (Genetic Diagnostic Network) is an international network of more than 100 laboratories specializing in genetic diagnostics, headquartered in Antwerp, Belgium. The company provides a comprehensive range of genetic tests, including non-invasive prenatal testing (NIPT), hereditary cancer screening, and diagnostics for rare genetic disorders. GENDIA acts as a central hub, coordinating complex genetic analyses and providing expert interpretation of results for clinicians and patients worldwide. Their services cover various medical fields such as oncology, cardiology, and pediatrics, utilizing advanced technologies like Next-Generation Sequencing (NGS). By integrating a vast network of specialized labs, GENDIA offers one of the most extensive portfolios of genetic tests available globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GENDIA.